Related Share your love Previous Post 24. SCOPE, DEFINITION AND AIMS OF PHARMACOVIGILANCE Next Post 26. REPORTING, EVALUATION, MONITORING, PREVENTING AND MANAGEMENT OF ADVERSE DRUG REACTIONS